Physician

Alan F Cutler, MD

According to 2025 Medicare claims, Alan Cutler, MD (NPI: 1366425787) practices gastroenterology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is DIGESTIVE HEALTH CONSULTANTS, PLC (NPI: 1710924170; TIN: 383416305) and primary practice location at 48334-3275.

Cutler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 542 traditional Medicare patients, billed 6,485 HCPCS/CPT codes, and received $202,461 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 2,079 prescription claims across 786 beneficiaries totaling $759,878 in drug costs, led by Linzess (Linaclotide). 2023 DME data shows 22 claims. Open Payments data shows 200 records totaling $55,772. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $258,191 and ending at $202,461. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $1,479,632 to $759,878. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	793	7,187	$258,191
2016	810	5,364	$225,945
2017	782	4,061	$198,483
2018	726	4,808	$182,147
2019	729	7,969	$199,855
2020	580	4,509	$185,928
2021	609	7,780	$250,091
2022	650	4,819	$196,947
2023	544	10,962	$293,656
2024	542	6,485	$202,461

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	485	1,194	$1,479,632
2016	461	1,269	$1,343,008
2017	486	1,381	$893,723
2018	479	1,385	$740,283
2019	542	1,514	$652,985
2020	503	1,514	$720,783
2021	549	1,640	$524,569
2022	657	1,799	$545,461
2023	687	1,791	$880,055
2024	786	2,079	$759,878

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$198
2016	N/R	11	$592
2017	N/R	22	$505
2018	N/R	41	$1,173
2019	N/R	37	$1,189
2020	N/R	12	$299
2021	N/R	11	$665
2022	N/R	23	$974
2023	N/R	22	$930
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	51	51	$216
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	64	64	$188
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	137	189	$94
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	76	76	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	154	222	$67

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Linzess	Linaclotide	163	7,620	$132,740
Humira(Cf) Pen	Adalimumab	13	364	$85,267
Mesalamine	Mesalamine	57	3,312	$32,947
Zenpep	Lipase/Protease/Amylase	20	840	$31,421
Creon	Lipase/Protease/Amylase	14	747	$28,924

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	189	$25,151	Phathom Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	11	$30,621	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan F. Cutler, MD?

Tedicare shows public-source Medicare data for Alan F. Cutler, MD (NPI 1366425787), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan F. Cutler, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan F. Cutler, MD?

Alan F. Cutler, MD is linked to DIGESTIVE HEALTH CONSULTANTS, PLC (billing NPI 1710924170) in the available physician profile data.

Does Alan F. Cutler, MD have Open Payments data?

Alan F. Cutler, MD has 200 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.